Series E - Merrimack Pharmaceuticals - Apr 3, 2006 Funding Round Profile - Cointime

Bitcoin $97,704.00 +0.26%
Ethereum $3,286.66 -1.76%
BNB $620.92 -0.54%
Optimism $2.16 +3.42%
Arbitrum $0.79 -1.40%
Solana $255.10 +4.02%
Polygon $0.45 -0.16%
Cosmos $6.89 +6.96%
Avalanche $38.13 +7.17%

Bitcoin $97,704.00 +0.26%
Ethereum $3,286.66 -1.76%
BNB $620.92 -0.54%
Optimism $2.16 +3.42%
Arbitrum $0.79 -1.40%
Solana $255.10 +4.02%
Polygon $0.45 -0.16%
Cosmos $6.89 +6.96%
Avalanche $38.13 +7.17%

Merrimack Pharmaceuticals

company

Funding Round

Series E

Money Raised

$ 65M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
WT Investment Advisors Fund	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 20, 2005	Debt Financing	$ 9M	Hercules Capital	Detail
Mar 25, 2004	Grant	0	National Institutes of Health	Detail
Apr 20, 2005	Series D	$ 28.30M	WT Investment Advisors Fund	Detail
May 5, 2004	Series C	$ 28M	Wharton Capital	Detail